European Union - English - EMA (European Medicines Agency)

zoetis belgium sa - one of the following inactivated bluetongue virus strains:inactivated bluetongue virus, serotype 1, strain btv-1/alg2006/01 e1inactivated bluetongue virus, serotype 8, strain btv-8/bel2006/02inactivated bluetongue virus, serotype 4, strain spa-1/2004 - immunologicals, immunologicals for bovidae, inactivated viral vaccines, bluetongue virus, sheep - sheep; cattle - active immunisation of sheep from 6 weeks of age for the prevention of viraemia caused by bluetongue virus, serotypes 1 and 8, and for the reduction of viraemia caused by bluetongue virus, serotype 4 and active immunisation of cattle from 12 weeks of age for the prevention of viraemia caused by bluetongue virus, serotypes 1 and 8.

United States - English - NLM (National Library of Medicine)

bioactive nutritional, inc. - bos taurus spleen (unii: 190q9mb3u3) (bos taurus spleen - unii:190q9mb3u3) - bos taurus spleen 6 [hp_x] in 1 ml - for temporary relief of symptoms due to spleen dysregulation. for temporary relief of symptoms due to spleen dysregulation.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

pharmalink marketing australia pty ltd - green lipped mussel - unknown - green lipped mussel extract-animal active 0.0 - active constituent

Australia - English - Department of Health (Therapeutic Goods Administration)

bristol-myers squibb australia pty ltd - lomustine, quantity: 40 mg - capsule, hard - excipient ingredients: gelatin; indigo carmine; magnesium stearate; mannitol; titanium dioxide; iron oxide yellow; butan-1-ol; shellac; iron oxide black - (1) brain tumours (primary and secondary). (2) hodgkin's disease (as secondary therapy). lomustine is used in addition to appropriate surgical and/or radiotherapeutic procedures or as a component of various chemotherapeutic regimens in the palliative treatment of primary and metastatic brain tumours. ceenu containing combinations should be used as alternative therapy in the treatment of disseminated hodgkin's disease in patients refractory to other established treatment regimens.

Australia - English - Department of Health (Therapeutic Goods Administration)

star combo australia pty ltd - green lipped mussel, quantity: 200 mg - capsule, soft - excipient ingredients: purified water; soya oil; titanium dioxide; gelatin; sunset yellow fcf; hydrogenated coconut oil; white beeswax; d-alpha-tocopherol; brilliant blue fcf; glycerol; lecithin; allura red ac; ethyl vanillin - maintain/support general health and wellbeing ; decrease/reduce/relieve mild joint aches and pains ; decrease/reduce/relieve symptoms of mild arthritis/mild osteoarthritis ; helps enhance/promote healthy joint function ; decrease/reduce/relieve mild joint inflammation/swelling ; maintain/support joint mobility/flexibility ; decrease/reduce/relieve mild joint pain/soreness ; decrease/reduce/relieve mild joint stiffness

Australia - English - Department of Health (Therapeutic Goods Administration)

pung lim international pty ltd - green lipped mussel, quantity: 750 mg; magnesium stearate, quantity: 1 mg - capsule, hard - excipient ingredients: croscarmellose sodium; colloidal anhydrous silica; purified water; gelatin; sodium lauryl sulfate - maintaining the general well-being

United States - English - NLM (National Library of Medicine)

novadaq technologies, inc. - indocyanine green (unii: ix6j1063hv) (indocyanine green acid form - unii:c4v974v932) - indocyanine green 25 mg - for determining cardiac output, hepatic function and liver blood flow, and for ophthalmic angiography. ic‑green™ contains sodium iodide and should be used with caution in patients who have a history of allergy to iodides.

United States - English - NLM (National Library of Medicine)

novadaq technologies inc. - indocyanine green (unii: ix6j1063hv) (indocyanine green - unii:ix6j1063hv) - indocyanine green 25 mg - for determining cardiac output, hepatic function and liver blood flow, and for ophthalmic angiography. indocyanine green for injection usp contains sodium iodide and should be used with caution in patients who have a history of allergy to iodides.

United States - English - NLM (National Library of Medicine)

novadaq technologies inc. - indocyanine green (unii: ix6j1063hv) (indocyanine green acid form - unii:c4v974v932) - indocyanine green 25 mg - for determining cardiac output, hepatic function and liver blood flow, and for ophthalmic angiography. indocyanine green for injection usp contains sodium iodide and should be used with caution in patients who have a history of allergy to iodides.

United States - English - NLM (National Library of Medicine)

akorn - indocyanine green (unii: ix6j1063hv) (indocyanine green acid form - unii:c4v974v932) - indocyanine green 25 mg - ic-green® is indicated: ic-green® contains sodium iodide and should be used with caution in patients who have a history of allergy to iodides because of the risk of anaphylaxis. animal reproduction studies have not been conducted with ic-green® . it is also not known whether ic-green® can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. ic-green® should be given to a pregnant woman only if clearly indicated. it is not known whether this drug is excreted in human milk. because many drugs are excreted in human milk, caution should be exercised when ic-green® is administered to a nursing woman. safety and effectiveness in pediatric patients have been established. see dosage and administration (2) for specific dosing information in pediatric patients. no overall differences in safety or effectiveness have been observed between elderly and younger patients.